In patients with chronic obstructive pulmonary disease, stimulation of muscarinic acetylcholine receptors results in an increase in mucus secretion, smooth muscle contraction and bronchoconstriction. The end result is an increase in airway resistance. Which of the following pharmacologic agents interferes directly with this pathway?
AEpinephrine
BAlbuterol
CTheophylline
DIpratropium
EMetoprolol
A 29-year-old man presents for the evaluation of infertility. He has a history of recurrent lower respiratory tract infections, productive cough, abdominal pain, and diarrhea. Physical examination reveals clubbing and bilateral crackles on chest auscultation. Chest X-ray reveals increased pulmonary markings and peripheral bronchi with a ‘tram track’ appearance. Which of the following pathophysiologies is responsible for the patient’s condition?
AFibrosis of the lung parenchyma
BBronchial hypersensitivity
CAbnormal ciliary motion
DGluten hypersensitivity
EDefective chloride transport
A 28-year-old man presents to his primary care provider because of shortness of breath, cough, and wheezing. He reports that in high school, he occasionally had shortness of breath and would wheeze after running. His symptoms have progressively worsened over the past 6 months and are now occurring daily. He also finds himself being woken up from sleep by his wheeze approximately 3 times a week. His medical history is unremarkable. He denies tobacco use or excessive alcohol consumption. His temperature is 37.1°C (98.8°F), blood pressure is 121/82 mm Hg, and heart rate is 82/min. Physical examination is remarkable for expiratory wheezing bilaterally. Spirometry shows an FEV1 of 73% of predicted, which improves by 19% with albuterol. In addition to a short-acting beta-agonist as needed, which of the following is the most appropriate therapy for this patient?
AA high-dose inhaled corticosteroid and a long-acting beta-agonist
BA long-acting beta-agonist alone
CA low-dose inhaled corticosteroid alone
DA medium-dose inhaled corticosteroid and a long-acting beta-agonist
EA low-dose inhaled corticosteroid and a long-acting beta-agonist
+ 7 more in the PDF
Browse all chapters